Vir Biotechnology, Inc. Payments to Acquire Assets, Investing Activities
Vir Biotechnology, Inc. (VIR) reported Payments to Acquire Assets, Investing Activities of $1.74 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAssetsInvestingActivities · last filed 2021-02-25
- Vir Biotechnology, Inc. payments to acquire assets, investing activities for the quarter ending 2018-12-31 was $0.00.
- Vir Biotechnology, Inc. payments to acquire assets, investing activities for fiscal 2018 was $1.74M.
| Period end | Payments to Acquire Assets, Investing Activities 3 month | Payments to Acquire Assets, Investing Activities 9 month | Payments to Acquire Assets, Investing Activities 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.74M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $1.74M 10-Q · filed 2019-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |